Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

175 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2-positive early breast cancer: real-world data from NeoPowER study.
Canino F, Barbolini M, De Giorgi U, Fontana T, Gaspari V, Gianni C, Gianni L, Maestri A, Minichillo S, Moscetti L, Mura A, Nicoletti SVL, Omarini C, Pagani R, Sarti S, Toss A, Zamagni C, Cuoghi Costantini R, Caggia F, Antonelli G, Baglio F, Belluzzi L, Martinelli G, Natalizio S, Ponzoni O, Dominici M, Piacentini F. Canino F, et al. Among authors: zamagni c. BMC Cancer. 2024 Jun 15;24(1):735. doi: 10.1186/s12885-024-12506-0. BMC Cancer. 2024. PMID: 38879498 Free PMC article.
Brio: A European Prospective Observational Study to Assess the Burden of Disease and Treatment in Metastatic Breast Cancer (Mbc) Patients Treated with Oral Vinorelbine (Nvboral) or Intravenous Vinorelbine (Ivvino).
Barni S, Mouysset JL, Sediva M, Zamagni C, Garau I. Barni S, et al. Among authors: zamagni c. Value Health. 2014 Nov;17(7):A647. doi: 10.1016/j.jval.2014.08.2345. Epub 2014 Oct 26. Value Health. 2014. PMID: 27202329 Free article. No abstract available.
Haptoglobin phenotype and epithelial ovarian cancer.
Mandato VD, Magnani E, Abrate M, Casali B, Nicoli D, Farnetti E, Formisano D, Pirillo D, Ciarlini G, De Iaco P, Strada I, Zamagni C, La Sala GB. Mandato VD, et al. Among authors: zamagni c. Anticancer Res. 2012 Oct;32(10):4353-8. Anticancer Res. 2012. PMID: 23060558
Pharmacokinetics of third-generation aromatase inhibitors.
Lønning P, Pfister C, Martoni A, Zamagni C. Lønning P, et al. Among authors: zamagni c. Semin Oncol. 2003 Aug;30(4 Suppl 14):23-32. doi: 10.1016/s0093-7754(03)00305-1. Semin Oncol. 2003. PMID: 14513434 Review.
BRCA-associated ovarian cancer: from molecular genetics to risk management.
Girolimetti G, Perrone AM, Santini D, Barbieri E, Guerra F, Ferrari S, Zamagni C, De Iaco P, Gasparre G, Turchetti D. Girolimetti G, et al. Among authors: zamagni c. Biomed Res Int. 2014;2014:787143. doi: 10.1155/2014/787143. Epub 2014 Jul 22. Biomed Res Int. 2014. PMID: 25136623 Free PMC article. Review.
Chemotherapy of advanced ovarian cancer.
Martoni A, Cacciari N, Angelelli B, Zamagni C, Pannuti F. Martoni A, et al. Among authors: zamagni c. Front Biosci. 1997 Mar 15;2:g20-6. Front Biosci. 1997. PMID: 9159262
Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective study.
Bengala C, Zamagni C, Pedrazzoli P, Matteucci P, Ballestrero A, Da Prada G, Martino M, Rosti G, Danova M, Bregni M, Jovic G, Guarneri V, Maur M, Conte PF; Gruppo Italiano Trapianto Midollo Osseo (GITMO) Group. Bengala C, et al. Among authors: zamagni c. Br J Cancer. 2006 Apr 10;94(7):1016-20. doi: 10.1038/sj.bjc.6603060. Br J Cancer. 2006. PMID: 16570045 Free PMC article.
175 results